Low prevalence of coeliac disease in patients with systemic sclerosis: A cross-sectional study of a registry cohort

Lindsy J. Forbess, Jessica K. Gordon, Kamini Doobay, Brian P. Bosworth, Stephen Lyman, Morgana L. Davids, Robert F. Spiera

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Objectives. Two prior studies suggested that coeliac disease (CD) has a higher prevalence rate (8%) in SSc than in the general population (1%), but these studies were limited by small numbers and the use of traditional coeliac screening antibody tests, where newer ones with improved accuracy have since emerged. Our aim was to determine the prevalence of CD in a larger SSc population using a more modern serological approach to coeliac testing and to correlate coeliac antibody status with gastrointestinal symptoms.Methods. Stored sera from 72 SSc patients in the Scleroderma Registry at the Hospital for Special Surgery were tested for anti-tissue transglutaminase (traditional) and anti-deamidated gliadin peptide (novel) antibodies. If any of these antibodies were positive, anti-endomysial antibodies were tested and confirmatory small-bowel endoscopy and biopsy were obtained. Registry clinical data were used to determine whether antibody status correlated with gastrointestinal symptoms.Results. The prevalence of coeliac antibodies in our SSc population was 3/72 (4%). No significant differences with respect to gastrointestinal symptoms were seen in the coeliac antibody-positive compared with -negative SSc patients. No cases of confirmed CD were seen in our cohort.Conclusion. Contrary to the only two previously published studies, the low prevalence of CD that we found does not suggest that concurrent CD is a common cause of gastrointestinal complaints in SSc patients.

Original languageEnglish
Article numberkes390
Pages (from-to)939-943
Number of pages5
JournalRheumatology (United Kingdom)
Volume52
Issue number5
DOIs
Publication statusPublished - May 1 2013

Fingerprint

Systemic Scleroderma
Celiac Disease
Registries
Cross-Sectional Studies
Abdomen
Antibodies
Special Hospital
Population
Gliadin
Endoscopy
Anti-Idiotypic Antibodies
Biopsy
Peptides
Serum

All Science Journal Classification (ASJC) codes

  • Rheumatology
  • Pharmacology (medical)

Cite this

Low prevalence of coeliac disease in patients with systemic sclerosis : A cross-sectional study of a registry cohort. / Forbess, Lindsy J.; Gordon, Jessica K.; Doobay, Kamini; Bosworth, Brian P.; Lyman, Stephen; Davids, Morgana L.; Spiera, Robert F.

In: Rheumatology (United Kingdom), Vol. 52, No. 5, kes390, 01.05.2013, p. 939-943.

Research output: Contribution to journalArticle

Forbess, Lindsy J. ; Gordon, Jessica K. ; Doobay, Kamini ; Bosworth, Brian P. ; Lyman, Stephen ; Davids, Morgana L. ; Spiera, Robert F. / Low prevalence of coeliac disease in patients with systemic sclerosis : A cross-sectional study of a registry cohort. In: Rheumatology (United Kingdom). 2013 ; Vol. 52, No. 5. pp. 939-943.
@article{7184f972767549ebb3e83ebd704b9487,
title = "Low prevalence of coeliac disease in patients with systemic sclerosis: A cross-sectional study of a registry cohort",
abstract = "Objectives. Two prior studies suggested that coeliac disease (CD) has a higher prevalence rate (8{\%}) in SSc than in the general population (1{\%}), but these studies were limited by small numbers and the use of traditional coeliac screening antibody tests, where newer ones with improved accuracy have since emerged. Our aim was to determine the prevalence of CD in a larger SSc population using a more modern serological approach to coeliac testing and to correlate coeliac antibody status with gastrointestinal symptoms.Methods. Stored sera from 72 SSc patients in the Scleroderma Registry at the Hospital for Special Surgery were tested for anti-tissue transglutaminase (traditional) and anti-deamidated gliadin peptide (novel) antibodies. If any of these antibodies were positive, anti-endomysial antibodies were tested and confirmatory small-bowel endoscopy and biopsy were obtained. Registry clinical data were used to determine whether antibody status correlated with gastrointestinal symptoms.Results. The prevalence of coeliac antibodies in our SSc population was 3/72 (4{\%}). No significant differences with respect to gastrointestinal symptoms were seen in the coeliac antibody-positive compared with -negative SSc patients. No cases of confirmed CD were seen in our cohort.Conclusion. Contrary to the only two previously published studies, the low prevalence of CD that we found does not suggest that concurrent CD is a common cause of gastrointestinal complaints in SSc patients.",
author = "Forbess, {Lindsy J.} and Gordon, {Jessica K.} and Kamini Doobay and Bosworth, {Brian P.} and Stephen Lyman and Davids, {Morgana L.} and Spiera, {Robert F.}",
year = "2013",
month = "5",
day = "1",
doi = "10.1093/rheumatology/kes390",
language = "English",
volume = "52",
pages = "939--943",
journal = "Rheumatology",
issn = "1462-0324",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Low prevalence of coeliac disease in patients with systemic sclerosis

T2 - A cross-sectional study of a registry cohort

AU - Forbess, Lindsy J.

AU - Gordon, Jessica K.

AU - Doobay, Kamini

AU - Bosworth, Brian P.

AU - Lyman, Stephen

AU - Davids, Morgana L.

AU - Spiera, Robert F.

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Objectives. Two prior studies suggested that coeliac disease (CD) has a higher prevalence rate (8%) in SSc than in the general population (1%), but these studies were limited by small numbers and the use of traditional coeliac screening antibody tests, where newer ones with improved accuracy have since emerged. Our aim was to determine the prevalence of CD in a larger SSc population using a more modern serological approach to coeliac testing and to correlate coeliac antibody status with gastrointestinal symptoms.Methods. Stored sera from 72 SSc patients in the Scleroderma Registry at the Hospital for Special Surgery were tested for anti-tissue transglutaminase (traditional) and anti-deamidated gliadin peptide (novel) antibodies. If any of these antibodies were positive, anti-endomysial antibodies were tested and confirmatory small-bowel endoscopy and biopsy were obtained. Registry clinical data were used to determine whether antibody status correlated with gastrointestinal symptoms.Results. The prevalence of coeliac antibodies in our SSc population was 3/72 (4%). No significant differences with respect to gastrointestinal symptoms were seen in the coeliac antibody-positive compared with -negative SSc patients. No cases of confirmed CD were seen in our cohort.Conclusion. Contrary to the only two previously published studies, the low prevalence of CD that we found does not suggest that concurrent CD is a common cause of gastrointestinal complaints in SSc patients.

AB - Objectives. Two prior studies suggested that coeliac disease (CD) has a higher prevalence rate (8%) in SSc than in the general population (1%), but these studies were limited by small numbers and the use of traditional coeliac screening antibody tests, where newer ones with improved accuracy have since emerged. Our aim was to determine the prevalence of CD in a larger SSc population using a more modern serological approach to coeliac testing and to correlate coeliac antibody status with gastrointestinal symptoms.Methods. Stored sera from 72 SSc patients in the Scleroderma Registry at the Hospital for Special Surgery were tested for anti-tissue transglutaminase (traditional) and anti-deamidated gliadin peptide (novel) antibodies. If any of these antibodies were positive, anti-endomysial antibodies were tested and confirmatory small-bowel endoscopy and biopsy were obtained. Registry clinical data were used to determine whether antibody status correlated with gastrointestinal symptoms.Results. The prevalence of coeliac antibodies in our SSc population was 3/72 (4%). No significant differences with respect to gastrointestinal symptoms were seen in the coeliac antibody-positive compared with -negative SSc patients. No cases of confirmed CD were seen in our cohort.Conclusion. Contrary to the only two previously published studies, the low prevalence of CD that we found does not suggest that concurrent CD is a common cause of gastrointestinal complaints in SSc patients.

UR - http://www.scopus.com/inward/record.url?scp=84876715892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876715892&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/kes390

DO - 10.1093/rheumatology/kes390

M3 - Article

C2 - 23335635

AN - SCOPUS:84876715892

VL - 52

SP - 939

EP - 943

JO - Rheumatology

JF - Rheumatology

SN - 1462-0324

IS - 5

M1 - kes390

ER -